MicroPort NeuroScientific Corporation (HKG:2172)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.34
+0.08 (0.65%)
Jun 6, 2025, 4:08 PM HKT
43.66%
Market Cap 7.10B
Revenue (ttm) 810.65M
Net Income (ttm) 270.48M
Shares Out 575.62M
EPS (ttm) 0.47
PE Ratio 26.42
Forward PE 22.39
Dividend 0.22 (1.78%)
Ex-Dividend Date Jul 2, 2025
Volume 14,890,000
Average Volume 7,548,412
Open 12.28
Previous Close 12.26
Day's Range 11.96 - 12.82
52-Week Range 6.21 - 15.24
Beta -0.14
RSI 66.93
Earnings Date May 28, 2025

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk; Tubridge, a flow-diverting stent; Willis, an intracranial stent graft system; Comaneci, an adjustable temporary coil embolization device; and Rebridge, an intracranial visualized stent for use in the treatment of hemorrhagic stroke. It also offers Neuro... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 527
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2172
Full Company Profile

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.